Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
KPC Pharmaceuticals Inc (KPC Pharmaceuticals) is a producer of natural botanical drugs. The company carries out drug research and development, production, sales, commercial wholesale, and international marketing. It offers luotai injection, luotai soft capsule, xuesaitong injection, gastrodine tablets, acetagastrodin tablets, gastrodin injection, gastrodin capsules, helicid drugs, compound artemisia spray, qiyeshen’an tablets, artemisinin and naphthoquine phosphate tablets, comether tablets, artemether injection and artemesinin-based combination therapy (act) antimalarial drugs among others. KPC Pharmaceuticals markets its products under the brands Luotai, Tianxuanqing, Artemedine, Artem and Arco. The company's products are used for the treatment of central nervous system disorders, cardiovascular, cardio-cerebral-vascular, chronic disease, disorders, and malaria. It has operations across Europe, Africa, Oceania, and South America. KPC is headquartered in Kunming, Yunnan, China.
KPC Pharmaceuticals Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Panax Notoginseng: | Luotai |
| Luotai Injection | Tianxuanqing |
| Luotai Soft Capsule | Artemedine |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | KPC Pharmaceuticals Inc | Shenzhen Neptunus Bioengineering Co Ltd | Tasly Pharmaceutical Group Co Ltd | Jiangsu Nhwa Pharmaceutical Co Ltd | Guizhou YiBai Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Kunming | Shenzhen | Tianjin | Xuzhou | Guiyang |
| State/Province | Yunnan | Guangdong | Tianjin | Jiangsu | Guizhou |
| No. of Employees | 5,072 | 6,734 | 10,563 | 6,003 | 4,832 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Yu Xiang | Chairman | Executive Board | - | - |
| Yan Wei | Vice Chairman | Executive Board | - | - |
| Deng Kang | Vice Chairman | Executive Board | - | - |
| Zhong Jiang | President; Director | Executive Board | - | - |
| Sun Zhiqiang | Chief Financial Officer; Secretary | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer